http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 13 Aug 2026 14:21:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html <p align="justify">BROSSARD, Quebec, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that today, August 13, 2026, it has received Medical Device Marketing Authorization for the CARA System (CARA) from the Saudi Food and Drug Authority (SFDA).<br/><br/>The version of CARA licensed in Saudi Arabia includes detection algorithms for Diabetic Retinopathy (DR) and Age-related Macular Degeneration (AMD). CARA provides, in a short period of time and at an affordable unit http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html Thu, 13 Aug 2026 14:21:00 -0400 4D4A A.17150087 A.60012007 ADK DGNOF O.02535360 O.34929518 O.48414375 http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html <p align="justify">BROSSARD, Quebec, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that today, August 13, 2026, it has received Medical Device Marketing Authorization for the CARA System (CARA) from the Saudi Food and Drug Authority (SFDA).<br/><br/>The version of CARA licensed in Saudi Arabia includes detection algorithms for Diabetic Retinopathy (DR) and Age-related Macular Degeneration (AMD). CARA provides, in a short period of time and at an affordable unit http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html Thu, 13 Aug 2026 14:21:00 -0400 4D4A A.17150087 A.60012007 ADK DGNOF O.02535360 O.34929518 O.48414375 http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html <p align="justify">BROSSARD, Quebec, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that today, August 13, 2026, it has received Medical Device Marketing Authorization for the CARA System (CARA) from the Saudi Food and Drug Authority (SFDA).<br/><br/>The version of CARA licensed in Saudi Arabia includes detection algorithms for Diabetic Retinopathy (DR) and Age-related Macular Degeneration (AMD). CARA provides, in a short period of time and at an affordable unit http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html Thu, 13 Aug 2026 14:21:00 -0400 4D4A A.17150087 A.60012007 ADK DGNOF O.02535360 O.34929518 O.48414375 http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html <p align="justify">BROSSARD, Quebec, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that today, August 13, 2026, it has received Medical Device Marketing Authorization for the CARA System (CARA) from the Saudi Food and Drug Authority (SFDA).<br/><br/>The version of CARA licensed in Saudi Arabia includes detection algorithms for Diabetic Retinopathy (DR) and Age-related Macular Degeneration (AMD). CARA provides, in a short period of time and at an affordable unit http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html Thu, 13 Aug 2026 14:21:00 -0400 4D4A A.17150087 A.60012007 ADK DGNOF O.02535360 O.34929518 O.48414375 http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html <p align="justify">BROSSARD, Quebec, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that today, August 13, 2026, it has received Medical Device Marketing Authorization for the CARA System (CARA) from the Saudi Food and Drug Authority (SFDA).<br/><br/>The version of CARA licensed in Saudi Arabia includes detection algorithms for Diabetic Retinopathy (DR) and Age-related Macular Degeneration (AMD). CARA provides, in a short period of time and at an affordable unit http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html Thu, 13 Aug 2026 14:21:00 -0400 4D4A A.17150087 A.60012007 ADK DGNOF O.02535360 O.34929518 O.48414375 http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html <p align="justify">BROSSARD, Quebec, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that today, August 13, 2026, it has received Medical Device Marketing Authorization for the CARA System (CARA) from the Saudi Food and Drug Authority (SFDA).<br/><br/>The version of CARA licensed in Saudi Arabia includes detection algorithms for Diabetic Retinopathy (DR) and Age-related Macular Degeneration (AMD). CARA provides, in a short period of time and at an affordable unit http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html Thu, 13 Aug 2026 14:21:00 -0400 4D4A A.17150087 A.60012007 ADK DGNOF O.02535360 O.34929518 O.48414375 http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html <p align="justify">BROSSARD, Quebec, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that today, August 13, 2026, it has received Medical Device Marketing Authorization for the CARA System (CARA) from the Saudi Food and Drug Authority (SFDA).<br/><br/>The version of CARA licensed in Saudi Arabia includes detection algorithms for Diabetic Retinopathy (DR) and Age-related Macular Degeneration (AMD). CARA provides, in a short period of time and at an affordable unit http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html Thu, 13 Aug 2026 14:21:00 -0400 4D4A A.17150087 A.60012007 ADK DGNOF O.02535360 O.34929518 O.48414375 http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html <p align="justify">BROSSARD, Quebec, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that today, August 13, 2026, it has received Medical Device Marketing Authorization for the CARA System (CARA) from the Saudi Food and Drug Authority (SFDA).<br/><br/>The version of CARA licensed in Saudi Arabia includes detection algorithms for Diabetic Retinopathy (DR) and Age-related Macular Degeneration (AMD). CARA provides, in a short period of time and at an affordable unit http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html Thu, 13 Aug 2026 14:21:00 -0400 4D4A A.17150087 A.60012007 ADK DGNOF O.02535360 O.34929518 O.48414375 http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html <p align="justify">BROSSARD, Quebec, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that today, August 13, 2026, it has received Medical Device Marketing Authorization for the CARA System (CARA) from the Saudi Food and Drug Authority (SFDA).<br/><br/>The version of CARA licensed in Saudi Arabia includes detection algorithms for Diabetic Retinopathy (DR) and Age-related Macular Degeneration (AMD). CARA provides, in a short period of time and at an affordable unit http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html Thu, 13 Aug 2026 14:21:00 -0400 4D4A A.17150087 A.60012007 ADK DGNOF O.02535360 O.34929518 O.48414375 http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html <p align="justify">BROSSARD, Quebec, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that today, August 13, 2026, it has received Medical Device Marketing Authorization for the CARA System (CARA) from the Saudi Food and Drug Authority (SFDA).<br/><br/>The version of CARA licensed in Saudi Arabia includes detection algorithms for Diabetic Retinopathy (DR) and Age-related Macular Degeneration (AMD). CARA provides, in a short period of time and at an affordable unit http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html Thu, 13 Aug 2026 14:21:00 -0400 4D4A A.17150087 A.60012007 ADK DGNOF O.02535360 O.34929518 O.48414375 http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html <p align="justify">BROSSARD, Quebec, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that today, August 13, 2026, it has received Medical Device Marketing Authorization for the CARA System (CARA) from the Saudi Food and Drug Authority (SFDA).<br/><br/>The version of CARA licensed in Saudi Arabia includes detection algorithms for Diabetic Retinopathy (DR) and Age-related Macular Degeneration (AMD). CARA provides, in a short period of time and at an affordable unit http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html Thu, 13 Aug 2026 14:21:00 -0400 4D4A A.17150087 A.60012007 ADK DGNOF O.02535360 O.34929518 O.48414375 http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html <p align="justify">BROSSARD, Quebec, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that today, August 13, 2026, it has received Medical Device Marketing Authorization for the CARA System (CARA) from the Saudi Food and Drug Authority (SFDA).<br/><br/>The version of CARA licensed in Saudi Arabia includes detection algorithms for Diabetic Retinopathy (DR) and Age-related Macular Degeneration (AMD). CARA provides, in a short period of time and at an affordable unit http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html Thu, 13 Aug 2026 14:21:00 -0400 4D4A A.17150087 A.60012007 ADK DGNOF O.02535360 O.34929518 O.48414375 http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html <p align="justify">BROSSARD, Quebec, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that today, August 13, 2026, it has received Medical Device Marketing Authorization for the CARA System (CARA) from the Saudi Food and Drug Authority (SFDA).<br/><br/>The version of CARA licensed in Saudi Arabia includes detection algorithms for Diabetic Retinopathy (DR) and Age-related Macular Degeneration (AMD). CARA provides, in a short period of time and at an affordable unit http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html Thu, 13 Aug 2026 14:21:00 -0400 4D4A A.17150087 A.60012007 ADK DGNOF O.02535360 O.34929518 O.48414375 http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html <p align="justify">BROSSARD, Quebec, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that today, August 13, 2026, it has received Medical Device Marketing Authorization for the CARA System (CARA) from the Saudi Food and Drug Authority (SFDA).<br/><br/>The version of CARA licensed in Saudi Arabia includes detection algorithms for Diabetic Retinopathy (DR) and Age-related Macular Degeneration (AMD). CARA provides, in a short period of time and at an affordable unit http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html Thu, 13 Aug 2026 14:21:00 -0400 4D4A A.17150087 A.60012007 ADK DGNOF O.02535360 O.34929518 O.48414375 http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html <p align="justify">BROSSARD, Quebec, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that today, August 13, 2026, it has received Medical Device Marketing Authorization for the CARA System (CARA) from the Saudi Food and Drug Authority (SFDA).<br/><br/>The version of CARA licensed in Saudi Arabia includes detection algorithms for Diabetic Retinopathy (DR) and Age-related Macular Degeneration (AMD). CARA provides, in a short period of time and at an affordable unit http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html Thu, 13 Aug 2026 14:21:00 -0400 4D4A A.17150087 A.60012007 ADK DGNOF O.02535360 O.34929518 O.48414375 http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html <p align="justify">BROSSARD, Quebec, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that today, August 13, 2026, it has received Medical Device Marketing Authorization for the CARA System (CARA) from the Saudi Food and Drug Authority (SFDA).<br/><br/>The version of CARA licensed in Saudi Arabia includes detection algorithms for Diabetic Retinopathy (DR) and Age-related Macular Degeneration (AMD). CARA provides, in a short period of time and at an affordable unit http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Receives+Saudi+FDA+Medical+Device+License+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Saudi+Arabia/26919850.html Thu, 13 Aug 2026 14:21:00 -0400 4D4A A.17150087 A.60012007 ADK DGNOF O.02535360 O.34929518 O.48414375 http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Health+Canada+Medical+Device+Licence+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Canadian+Optometrists/26819222.html <p align="justify">BROSSARD, Quebec, July 27, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that, on July 23, 2026, it has received a <strong>Health Canada Medical Device Licence</strong> authorizing the commercialization of its <strong>CARA System</strong> in Canada.</p> <p align="justify">CARA System technology integrates AI-powered analysis modules within a single clinician-controlled workflow:</p> <ul><li><strong>CARA-AMDdetect</strong> – Age-related macular degeneration detection</li><li><strong>CARA-DR</strong> – Diabetic retinopathy detection</li><li><strong>CARA-MVA</strong> – Retinal microvascular analysis</li><li><strong>CARA-Enhancement</strong> – Advanced retinal image enhancement</li><li><strong>CARA-CWS</strong> - http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Health+Canada+Medical+Device+Licence+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Canadian+Optometrists/26819222.html Mon, 27 Jul 2026 15:20:00 -0400 4D4A A.06822034 A.17150087 ADK DGNOF O.02535360 O.20026344 O.34929518 http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Health+Canada+Medical+Device+Licence+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Canadian+Optometrists/26819222.html <p align="justify">BROSSARD, Quebec, July 27, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that, on July 23, 2026, it has received a <strong>Health Canada Medical Device Licence</strong> authorizing the commercialization of its <strong>CARA System</strong> in Canada.</p> <p align="justify">CARA System technology integrates AI-powered analysis modules within a single clinician-controlled workflow:</p> <ul><li><strong>CARA-AMDdetect</strong> – Age-related macular degeneration detection</li><li><strong>CARA-DR</strong> – Diabetic retinopathy detection</li><li><strong>CARA-MVA</strong> – Retinal microvascular analysis</li><li><strong>CARA-Enhancement</strong> – Advanced retinal image enhancement</li><li><strong>CARA-CWS</strong> - http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Health+Canada+Medical+Device+Licence+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Canadian+Optometrists/26819222.html Mon, 27 Jul 2026 15:20:00 -0400 4D4A A.06822034 A.17150087 ADK DGNOF O.02535360 O.20026344 O.34929518 http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Health+Canada+Medical+Device+Licence+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Canadian+Optometrists/26819222.html <p align="justify">BROSSARD, Quebec, July 27, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that, on July 23, 2026, it has received a <strong>Health Canada Medical Device Licence</strong> authorizing the commercialization of its <strong>CARA System</strong> in Canada.</p> <p align="justify">CARA System technology integrates AI-powered analysis modules within a single clinician-controlled workflow:</p> <ul><li><strong>CARA-AMDdetect</strong> – Age-related macular degeneration detection</li><li><strong>CARA-DR</strong> – Diabetic retinopathy detection</li><li><strong>CARA-MVA</strong> – Retinal microvascular analysis</li><li><strong>CARA-Enhancement</strong> – Advanced retinal image enhancement</li><li><strong>CARA-CWS</strong> - http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Health+Canada+Medical+Device+Licence+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Canadian+Optometrists/26819222.html Mon, 27 Jul 2026 15:20:00 -0400 4D4A A.06822034 A.17150087 ADK DGNOF O.02535360 O.20026344 O.34929518 http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Health+Canada+Medical+Device+Licence+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Canadian+Optometrists/26819222.html <p align="justify">BROSSARD, Quebec, July 27, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that, on July 23, 2026, it has received a <strong>Health Canada Medical Device Licence</strong> authorizing the commercialization of its <strong>CARA System</strong> in Canada.</p> <p align="justify">CARA System technology integrates AI-powered analysis modules within a single clinician-controlled workflow:</p> <ul><li><strong>CARA-AMDdetect</strong> – Age-related macular degeneration detection</li><li><strong>CARA-DR</strong> – Diabetic retinopathy detection</li><li><strong>CARA-MVA</strong> – Retinal microvascular analysis</li><li><strong>CARA-Enhancement</strong> – Advanced retinal image enhancement</li><li><strong>CARA-CWS</strong> - http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Health+Canada+Medical+Device+Licence+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Canadian+Optometrists/26819222.html Mon, 27 Jul 2026 15:20:00 -0400 4D4A A.06822034 A.17150087 ADK DGNOF O.02535360 O.20026344 O.34929518 http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Health+Canada+Medical+Device+Licence+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Canadian+Optometrists/26819222.html <p align="justify">BROSSARD, Quebec, July 27, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that, on July 23, 2026, it has received a <strong>Health Canada Medical Device Licence</strong> authorizing the commercialization of its <strong>CARA System</strong> in Canada.</p> <p align="justify">CARA System technology integrates AI-powered analysis modules within a single clinician-controlled workflow:</p> <ul><li><strong>CARA-AMDdetect</strong> – Age-related macular degeneration detection</li><li><strong>CARA-DR</strong> – Diabetic retinopathy detection</li><li><strong>CARA-MVA</strong> – Retinal microvascular analysis</li><li><strong>CARA-Enhancement</strong> – Advanced retinal image enhancement</li><li><strong>CARA-CWS</strong> - http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Health+Canada+Medical+Device+Licence+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Canadian+Optometrists/26819222.html Mon, 27 Jul 2026 15:20:00 -0400 4D4A A.06822034 A.17150087 ADK DGNOF O.02535360 O.20026344 O.34929518 http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Health+Canada+Medical+Device+Licence+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Canadian+Optometrists/26819222.html <p align="justify">BROSSARD, Quebec, July 27, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that, on July 23, 2026, it has received a <strong>Health Canada Medical Device Licence</strong> authorizing the commercialization of its <strong>CARA System</strong> in Canada.</p> <p align="justify">CARA System technology integrates AI-powered analysis modules within a single clinician-controlled workflow:</p> <ul><li><strong>CARA-AMDdetect</strong> – Age-related macular degeneration detection</li><li><strong>CARA-DR</strong> – Diabetic retinopathy detection</li><li><strong>CARA-MVA</strong> – Retinal microvascular analysis</li><li><strong>CARA-Enhancement</strong> – Advanced retinal image enhancement</li><li><strong>CARA-CWS</strong> - http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Health+Canada+Medical+Device+Licence+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Canadian+Optometrists/26819222.html Mon, 27 Jul 2026 15:20:00 -0400 4D4A A.06822034 A.17150087 ADK DGNOF O.02535360 O.20026344 O.34929518 http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Health+Canada+Medical+Device+Licence+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Canadian+Optometrists/26819222.html <p align="justify">BROSSARD, Quebec, July 27, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that, on July 23, 2026, it has received a <strong>Health Canada Medical Device Licence</strong> authorizing the commercialization of its <strong>CARA System</strong> in Canada.</p> <p align="justify">CARA System technology integrates AI-powered analysis modules within a single clinician-controlled workflow:</p> <ul><li><strong>CARA-AMDdetect</strong> – Age-related macular degeneration detection</li><li><strong>CARA-DR</strong> – Diabetic retinopathy detection</li><li><strong>CARA-MVA</strong> – Retinal microvascular analysis</li><li><strong>CARA-Enhancement</strong> – Advanced retinal image enhancement</li><li><strong>CARA-CWS</strong> - http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Health+Canada+Medical+Device+Licence+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Canadian+Optometrists/26819222.html Mon, 27 Jul 2026 15:20:00 -0400 4D4A A.06822034 A.17150087 ADK DGNOF O.02535360 O.20026344 O.34929518 http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Health+Canada+Medical+Device+Licence+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Canadian+Optometrists/26819222.html <p align="justify">BROSSARD, Quebec, July 27, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that, on July 23, 2026, it has received a <strong>Health Canada Medical Device Licence</strong> authorizing the commercialization of its <strong>CARA System</strong> in Canada.</p> <p align="justify">CARA System technology integrates AI-powered analysis modules within a single clinician-controlled workflow:</p> <ul><li><strong>CARA-AMDdetect</strong> – Age-related macular degeneration detection</li><li><strong>CARA-DR</strong> – Diabetic retinopathy detection</li><li><strong>CARA-MVA</strong> – Retinal microvascular analysis</li><li><strong>CARA-Enhancement</strong> – Advanced retinal image enhancement</li><li><strong>CARA-CWS</strong> - http://www.streetinsider.com/Press+Releases/DIAGNOS+Receives+Health+Canada+Medical+Device+Licence+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Canadian+Optometrists/26819222.html Mon, 27 Jul 2026 15:20:00 -0400 4D4A A.06822034 A.17150087 ADK DGNOF O.02535360 O.20026344 O.34929518 http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Receives+Health+Canada+Medical+Device+Licence+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Canadian+Optometrists/26819222.html <p align="justify">BROSSARD, Quebec, July 27, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that, on July 23, 2026, it has received a <strong>Health Canada Medical Device Licence</strong> authorizing the commercialization of its <strong>CARA System</strong> in Canada.</p> <p align="justify">CARA System technology integrates AI-powered analysis modules within a single clinician-controlled workflow:</p> <ul><li><strong>CARA-AMDdetect</strong> – Age-related macular degeneration detection</li><li><strong>CARA-DR</strong> – Diabetic retinopathy detection</li><li><strong>CARA-MVA</strong> – Retinal microvascular analysis</li><li><strong>CARA-Enhancement</strong> – Advanced retinal image enhancement</li><li><strong>CARA-CWS</strong> - http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Receives+Health+Canada+Medical+Device+Licence+for+CARA+System%2C+Bringing+AI-Assisted+Retinal+Image+Analysis+to+Canadian+Optometrists/26819222.html Mon, 27 Jul 2026 15:20:00 -0400 4D4A A.06822034 A.17150087 ADK DGNOF O.02535360 O.20026344 O.34929518